Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T08:27:52.703Z Has data issue: false hasContentIssue false

Stress Responsivity in Childhood and Adulthood: Role of the Glucocorticoid Receptor Gene

Published online by Cambridge University Press:  16 April 2020

S. Claes
Affiliation:
Department of Psychiatry, University Hospitals Leuven, Leuven
D. van West
Affiliation:
University Centre Child and Adolescent Psychiatry, Antwerpen, Belgium
J. Del-Favero
Affiliation:
VIB8, University of Antwerpen, Antwerpen, Belgium
D. Deboutte
Affiliation:
University Centre Child and Adolescent Psychiatry, Antwerpen, Belgium

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims:

Prenatal stress has been associated with lifelong disturbances in stress response systems and with an increased vulnerability for psychiatric disorders. However, the effect of prenatal stress is at least partially determined by individual genetic makeup. Recent data confim the potential role of the glucocorticoid receptor (GR) gene in modulating stress response and in the liability to develop mood disorders. In genetic association studies, single nucleotide polymorphisms (SNPs) in the GR gene were linked to variation in stress response systems (1). In a preliminary investigation, we studied 106 prepubertal children to estimate the impact of four GR gene polymorphisms on cortisol responses after a psychosocial stress test.

Results:

Carriers of the ER22/23EK mutation displayed significant lower cortisol responses to psychosocial stress compared to noncarriers. This particular polymorphism has earlier been associated to the vulnerability to develop MDD by our own research group (2) and independently by another publication (3).

Conclusion:

These findings support the relevance of GR gene polymorphisms in general and of the ER22/23EK polymorphism in particular in HPA axis regulation and in the vulnerability for psychiatric disorders.

Type
S63-04
Copyright
Copyright © European Psychiatric Association 2009

References

References:

Derijk, R.H., de Kloet, E.R. Eur J Pharmacol 2008; 583: 303311Google Scholar
van West, D., et al. Neuropsychopharmacol 2006; 31: 602607Google Scholar
Van Rossum, E.F.C., et al. Biol Psychiatry 2006; 59: 681688Google Scholar
Submit a response

Comments

No Comments have been published for this article.